Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/64493
Type
ArticleCopyright
Restricted access
Embargo date
2030-12-31
Collections
Metadata
Show full item record
EPIDEMIOLOGY OF GROUP B STREPTOCOCCUS IN DEVELOPING COUNTRIES
Author
Affilliation
Jawaharlal Nehru University. School of Life Sciences. New Delhi, India.
Jawaharlal Nehru University. School of Life Sciences. New Delhi, India.
Jawaharlal Nehru University. School of Life Sciences. New Delhi, India.
Jawaharlal Nehru University. School of Environmental Sciences. New Delhi, India.
Capital Medical University. Department of Microbiology and Immunology. Beijing Children’s Hospital. Beijing, China.
Novartis Vaccines and Diagnostics. Siena, Italy.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
Novartis Vaccines and Diagnostics. Siena, Italy.
Novartis Vaccines and Diagnostics. Siena, Italy.
Novartis Vaccine Institute for Global Health. Siena, Italy.
Emory University. Rollins School of Public Health. Hubert Department of Global Health. Atlanta, GA, USA.
Cincinnati Children’s Hospital. Center for Global Health. Cincinnati, USA.
Jawaharlal Nehru University. School of Life Sciences. New Delhi, India.
Jawaharlal Nehru University. School of Life Sciences. New Delhi, India.
Jawaharlal Nehru University. School of Environmental Sciences. New Delhi, India.
Capital Medical University. Department of Microbiology and Immunology. Beijing Children’s Hospital. Beijing, China.
Novartis Vaccines and Diagnostics. Siena, Italy.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
Novartis Vaccines and Diagnostics. Siena, Italy.
Novartis Vaccines and Diagnostics. Siena, Italy.
Novartis Vaccine Institute for Global Health. Siena, Italy.
Emory University. Rollins School of Public Health. Hubert Department of Global Health. Atlanta, GA, USA.
Cincinnati Children’s Hospital. Center for Global Health. Cincinnati, USA.
Abstract
Group B Streptococcus (GBS) causes pneumonia, meningitis and sepsis in neonates. The current distribution pattern of GBS serotypes in developing countries such as India, China and Brazil is not clear. In order to appropriately plan for vaccination programs to address the burden of this disease in these countries, prospective population based studies are urgently needed. In our discussions, we focused on India, China and Brazil because of the membership of our workgroup, but data on other countries are also presented here. Further studies in developing countries are needed so as to better formulate appropriate public health interventions.
Share